| Personal venture | Managing Dir.-CEO: (interim) Halfon (Philippe) [founder, born 1960, M.D., Ph.D., Alphabio (CEO)] Sc.Dir.-CSO: Benech (Philippe) [Ph.D., ex-CNRS] Fin.Dir.-CFO: Corroy (Jean-Paul) [Sup de Co, ex-Alphabio] BusDev: Financers (Hist.): | Turnover (M€) : 0.18 (2008), 0.015 (2006) Total funding (M€) : n.a. Last funding (M€) : n.a. Focus : Virus Position : Preclin Company confirm : neutral |